HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nam Jin Yoo Selected Research

RNA-Induced Silencing Complex

5/2013Loss of RNA-induced silencing complex-related proteins in non-small cell lung cancers.
4/2010Immunohistochemical analysis of RNA-induced silencing complex-related proteins AGO2 and TNRC6A in prostate and esophageal cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nam Jin Yoo Research Topics

Disease

117Neoplasms (Cancer)
01/2021 - 06/2002
59Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 09/2003
45Carcinoma (Carcinomatosis)
07/2013 - 06/2003
25Microsatellite Instability
01/2021 - 12/2006
24Stomach Neoplasms (Stomach Cancer)
01/2018 - 04/2002
22Carcinogenesis
07/2018 - 08/2002
15Adenocarcinoma
07/2011 - 11/2002
14Leukemia
01/2020 - 07/2004
10Hepatocellular Carcinoma (Hepatoma)
07/2011 - 07/2004
9Breast Neoplasms (Breast Cancer)
07/2014 - 07/2004
8Colonic Neoplasms (Colon Cancer)
03/2021 - 01/2007
8Lung Neoplasms (Lung Cancer)
05/2013 - 06/2002
7Prostatic Neoplasms (Prostate Cancer)
02/2020 - 07/2009
7Acute Coronary Syndrome
03/2014 - 05/2009
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2011 - 07/2003
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2013 - 06/2006
6Neoplasm Metastasis (Metastasis)
12/2007 - 06/2002
5Cardiovascular Diseases (Cardiovascular Disease)
03/2014 - 05/2009
5Myocardial Infarction
03/2014 - 11/2009
5Lymphatic Metastasis
01/2006 - 07/2003
4Inflammation (Inflammations)
01/2021 - 06/2007
4Adenocarcinoma of Lung
06/2006 - 09/2005
3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
04/2013 - 01/2009
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
07/2011 - 01/2010
3Lymphoma (Lymphomas)
01/2011 - 07/2004
2Chromosomal Instability (Chromosome Stability)
06/2014 - 10/2013
2Infarction (Infarctions)
03/2014 - 09/2009
2Death (Near-Death Experience)
03/2013 - 01/2011
2Adenosquamous Carcinoma
07/2011 - 06/2006
2Large Cell Carcinoma
07/2011 - 06/2006
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2010 - 04/2003
2Esophageal Squamous Cell Carcinoma
01/2010 - 01/2009
2Multiple Myeloma
01/2009 - 07/2004
2Adenoma (Adenomas)
04/2007 - 09/2003
2Squamous Cell Carcinoma of Head and Neck
03/2007 - 04/2005
2Renal Cell Carcinoma (Grawitz Tumor)
07/2004 - 03/2002

Drug/Important Bio-Agent (IBA)

53Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2002
20Phosphotransferases (Kinase)IBA
12/2014 - 04/2004
16Calcibiotic Root Canal SealerIBA
01/2021 - 04/2011
15DNA (Deoxyribonucleic Acid)IBA
12/2018 - 06/2003
10Codon (Codons)IBA
07/2015 - 04/2002
9CaspasesIBA
04/2010 - 06/2002
7Caspase 8 (Caspase-8)IBA
02/2005 - 04/2002
6NucleotidesIBA
01/2021 - 10/2005
6Caspase 10IBA
01/2010 - 04/2002
5Amino AcidsFDA Link
12/2014 - 09/2004
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2014 - 11/2009
5omega-Chloroacetophenone (Mace)IBA
03/2013 - 05/2009
5Caspase 9IBA
01/2010 - 11/2002
4Long Noncoding RNAIBA
10/2020 - 11/2018
4Messenger RNA (mRNA)IBA
03/2020 - 06/2008
4ErbB Receptors (EGF Receptor)IBA
11/2011 - 04/2005
4Caspase 3 (Caspase-3)IBA
01/2010 - 11/2002
4Caspase 6IBA
01/2010 - 08/2006
4beta CateninIBA
02/2007 - 11/2004
3Histones (Histone)IBA
03/2021 - 08/2014
3Melanocyte-Stimulating Hormones (MSH)IBA
10/2020 - 01/2009
3Transcription Factors (Transcription Factor)IBA
07/2018 - 03/2010
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
07/2016 - 01/2007
3Rosuvastatin Calcium (Crestor)FDA Link
03/2014 - 11/2009
3Gefitinib (Iressa)FDA Link
11/2011 - 04/2005
3NF-kappa B (NF-kB)IBA
01/2010 - 01/2009
3polyadenineIBA
07/2008 - 08/2007
2Adenosine Triphosphatases (ATPase)IBA
01/2018 - 11/2005
2Sirtuin 1IBA
01/2017 - 01/2010
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2017 - 08/2006
2Histone MethyltransferasesIBA
04/2016 - 08/2014
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2015 - 01/2010
2Cadherins (E-Cadherin)IBA
01/2015 - 08/2003
2Fas Ligand Protein (Fas Ligand)IBA
09/2013 - 04/2003
2RNA-Induced Silencing ComplexIBA
05/2013 - 04/2010
2Autophagy-Related Protein 5IBA
11/2011 - 07/2011
2Caspase 2IBA
10/2011 - 06/2004
2Tyrosine Kinase InhibitorsIBA
07/2011 - 04/2005
2Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
05/2011 - 09/2010
2MitogensIBA
09/2009 - 04/2004
2Mitogen-Activated Protein KinasesIBA
09/2009 - 04/2004
2I-kappa B KinaseIBA
08/2009 - 01/2009
2Caspase 1 (ICE Protease)IBA
06/2009 - 06/2008
2Peptide Hydrolases (Proteases)FDA Link
06/2009 - 04/2002
2C-Reactive ProteinIBA
05/2009 - 10/2007
2Beclin-1IBA
07/2008 - 12/2007
2endonuclease GIBA
06/2008 - 05/2008
2LipidsIBA
10/2007 - 02/2005
2Protein Kinases (Protein Kinase)IBA
06/2007 - 01/2006
2IntegrinsIBA
05/2007 - 07/2003
2Transforming Growth Factor beta (TGF-beta)IBA
04/2007 - 08/2005
2Apoptosis Inducing FactorIBA
12/2006 - 01/2006
1InflammasomesIBA
01/2021
1TNF Receptor-Associated Factor 3IBA
01/2021
1Leucine-Rich Repeat ProteinsIBA
01/2021
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
01/2021
1MHC class II transactivator proteinIBA
10/2020
1ConnexinsIBA
07/2020
1ClaudinsIBA
07/2020
1erythrocyte membrane band 4.1 protein (erythrocyte membrane band 4.1)IBA
07/2020
1Casein Kinase I (Casein Kinase 1)IBA
01/2020

Therapy/Procedure

6Therapeutics
10/2020 - 08/2006
6Percutaneous Coronary Intervention
03/2014 - 05/2009
3Drug Therapy (Chemotherapy)
07/2017 - 03/2003